Michael Zand – Page 1608

BRIEF-FDA approves Reneuron’s cryopreserved formulation of retinal stem cell therapy candidate – Reuters

2017-06-19 Michael Zand NEWS

Celyad reports promising early results at first dose level of the solid arm of the THINK trial – Nasdaq

Celyad reports promising early results at first dose level of the solid arm of the THINK trialNasdaqMONT-SAINT-GUIBERT, Belgium, June 19, 2017 (GLOBE NEWSWIRE) — Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery and… Continue reading

2017-06-19 Michael Zand NEWS

Celyad reports promising early results at first dose level of the solid arm of the THINK trial – Nasdaq

2017-06-19 Michael Zand NEWS

CRISPR Therapeutics AG (:CRSP) Shares Tick 1.44% For the Week … – Concord Register

CRISPR Therapeutics AG (:CRSP) Shares Tick 1.44% For the Week …Concord RegisterCRISPR Therapeutics AG (:CRSP) shares saw the needle move 1.44% on the week. The stock closed the most recent session at $14.81 after seeing 42691 …Insider Selling… Continue reading

2017-06-19 Michael Zand NEWS

CRISPR Therapeutics AG (:CRSP) Shares Tick 1.44% For the Week … – Concord Register

2017-06-19 Michael Zand NEWS

Synthetic Biology Market bTo Increase at Steady Growth Rate 2016-2026 – Medgadget (blog)

Synthetic Biology Market bTo Increase at Steady Growth Rate 2016-2026Medgadget (blog)Synthetic Biology is one of the breakthrough technologies developed by mankind from chemistry, biology, computer science and engineering which ultimately changed the a… Continue reading

2017-06-18 Michael Zand NEWS

Could Immunotherapy Be Used to Tackle Antibiotic Resistance? – Contagionlive.com

BRIEF-FDA approves Reneuron’s cryopreserved formulation of retinal stem cell therapy candidate
Reuters
Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news …

and more »

2017-06-18 Michael Zand NEWS

Hadasit sells stem cell co Cell Cure stake – Globes

GlobesHadasit sells stem cell co Cell Cure stakeGlobesBioTime decided to acquire full ownership of Cell Cure after it published in early May initial results for a number of people who participated in trial of its stem cell implants. These trials found … Continue reading

2017-06-18 Michael Zand NEWS

1
…
1,606
1,607
1,608
1,609
1,610
…
3,823

Contagionlive.com

Could Immunotherapy Be Used to Tackle Antibiotic Resistance?
Contagionlive.com
Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses the use of immunotherapy in tackling antibiotic resistance. Interview Transcript (slightly modified for readability): “I think this is …

and more »

Login

Cart

All posts by: Michael Zand

BRIEF-FDA approves Reneuron’s cryopreserved formulation of retinal stem cell therapy candidate – Reuters

Celyad reports promising early results at first dose level of the solid arm of the THINK trial – Nasdaq

Celyad reports promising early results at first dose level of the solid arm of the THINK trial – Nasdaq

CRISPR Therapeutics AG (:CRSP) Shares Tick 1.44% For the Week … – Concord Register

CRISPR Therapeutics AG (:CRSP) Shares Tick 1.44% For the Week … – Concord Register

Synthetic Biology Market bTo Increase at Steady Growth Rate 2016-2026 – Medgadget (blog)

Could Immunotherapy Be Used to Tackle Antibiotic Resistance? – Contagionlive.com

Hadasit sells stem cell co Cell Cure stake – Globes